Kca3.1-Related Cellular Signalling Involved in Cancer Proliferation

Christian G Calderón Artavia1, Francisco A Arvelo Álvarez2,3

  • 1Laboratorio de Fisiología y Biofísica, Instituto de Biología Experimental (IBE), Facultad de Ciencias, Universidad Central de Venezuela, christian.calderon@ciens.ucv.ve.

Insights

Potassium channels, particularly KCa3.1 (intermediate conductance calcium-activated potassium channel), are crucial in cancer cell proliferation and signaling. Targeting KCa3.1 offers a promising avenue for novel cancer chemotherapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biophysics

Background:

  • Anomalous potassium channel expression is linked to cancer hallmarks like proliferation and tumor progression.
  • The precise molecular mechanisms by which ion channels influence cancer cell proliferation remain largely unknown.
  • Calcium-dependent potassium channels are implicated in cell cycle signaling within numerous cancer cell lines.

Approach:

  • This review explores the role of the intermediate conductance calcium-activated potassium channel, KCa3.1 (IKCa), in cancer cell cycle signaling.
  • It examines how KCa3.1 activity, through canonical and non-canonical pathways, mediates proliferative signals.
  • The review also investigates KCa3.1's interaction with calcium channels in generating calcium signals.

Key Points:

  • KCa3.1 channels are significantly involved in uncontrolled cell cycle signaling and other malignant processes.
  • Extracellular mitogenic signals can modulate ion channel activity via intracellular secondary messengers.
  • KCa3.1 channels are amenable to specific pharmacological regulation, highlighting their therapeutic potential.

Conclusions:

  • Understanding KCa3.1's role in cell cycle signaling is vital for deciphering cancer progression.
  • KCa3.1 represents a promising target for developing new chemotherapeutic approaches against various cancers.
  • Further research into KCa3.1's function can illuminate signaling behaviors in diverse cancer types.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K